UHMontpellier
Montpellier, France, 34295
NCT Number: NCT02712086
The main objective will be to evaluate the effect at 5 weeks of nutritional management associated with protein supplementation (adapted to the post-operative period) on the maintenance of lean body mass at the whole body in obese patients after a sleeve gastrectomy.
Secondary objectives will assess protein intake, food safety, the effect of protein supplementation on body fat in the entire body and the metabolic rate and the impact on quality of life and post-operative joint pain.
Looking for future studies?
Notify Me18 year–60 year
All sexes
Interventional
Not applicable
Montpellier, France, 34295
The main objective will be to evaluate the effect at 5 weeks of nutritional management associated with protein supplementation (adapted to the post-operative period) on the maintenance of lean body mass at the whole body in obese patients after a sleeve gastrectomy.
Secondary objectives will assess protein intake, food safety, the effect of protein supplementation on body fat in the entire body and the metabolic rate and the impact on quality of life and post-operative joint pain.
There is still no study evaluating the protein supplementation adapted patients after sleeve gastrectomy on maintaining lean body mass.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Protein supplementation : Protein intake of 30 grams of protein in addition to the usual inputs (to the recommended amounts of 60 to 120 g per day), upon the resumption of oral intake until the fifth week after sleeve gastrectomy.
Time frame: up to 1 month
Time frame: 5 weeks after the hospital discharge
The actual protein intake will be assessed using a food diary over 5 weeks completed by the patient
Time frame: up to 1 month
change rate IGF1, IGFBP3 between hospitalization and 1 month of hospital discharge
Time frame: up to 1 month
The evolution of the quality of life will be assessed through a specific scale, Baros score.
Time frame: up to 5 years
The evolution of the quality of life will be assessed through a specific scale, Baros score.
Time frame: up to 5 years
change rate IGF1, IGFBP3 between hospitalization and 5 years follow up
University Hospital, Montpellier
Other
Randomized Controlled Trial Prospective Single-center Open Evaluating the Efficacy of Supplementation (Adapted to the Post-operative Period) Current Protein After Bariatric Surgery Like Sleeve Gastrectomy
Acronym: PROTISLEEVE
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05742165
Behavior, Body Weight
New York, United States
View Trial DetailsNCT05882045
Body Weight, Cardiovascular Diseases
Phoenix, Arizona, United States
View Trial DetailsNCT05929079
Apnea, Body Weight
Anniston, Alabama, United States
View Trial DetailsNCT00342732
Body Weight, Nutrition Disorders
Phoenix, Arizona, United States
View Trial Details